首页> 外文期刊>The Open Ophthalmology Journal >Dacryocystectomy with Lacrimal Silicone Intubation in Challenging Patients Affected by Recurrent Dacryocystitis and Epiphora: Expanding Minimally Invasive Approach Indications
【24h】

Dacryocystectomy with Lacrimal Silicone Intubation in Challenging Patients Affected by Recurrent Dacryocystitis and Epiphora: Expanding Minimally Invasive Approach Indications

机译:泪囊切除术治疗受复发性泪囊炎和Epiphora影响的挑战性患者:扩大微创方法适应症

获取原文
       

摘要

Objective: In this study, we evaluated the feasibility and safety of dacryocystectomy associated with lacrimal intubation, for the treatment of recurrent dacryocystitis and epiphora secondary to lacrimal obstruction with compromised lacrimal sac, was evaluated. Subjects and Methods: 32 patients underwent dacryocystectomy with Crawford tubes canalicular insertion, performed by a single surgeon. Post-operative visits were scheduled at 1st and 10th day, 1, 3, and 6 months. At each follow-up visit, the prevalence of epiphora and dacryocystitis was evaluated and compared with baseline data. Also, we evaluated the prevalence of local and systemic post-operative adverse events during the follow-up period. Results: 11 patients (34.38%) reported persistent epiphora, which lasted for 30 days after surgery. Among them, 9 subjects (28.13%) complained occasional epiphora even at the six months follow-up. In the event of dacryocystitis or subacute phlogosis before surgery, patients reported a definitive symptom resolution. Other reported adverse events were epithelial corneal erosion due to Crawford tube protrusion (4 cases, 12.5%), a Crawford tube extrusion case (3.13%), 3 cases of surgical wound dehiscence (9.36%), and a case of mild local bleeding persisting for 15 days Conclusion: A significative epiphora reduction was observed after surgery with an acceptable safety profile, expanding dacryocystectomy indications. This procedure provides a satisfactory resolution of recurrent dacryocystitis. However, this approach should be performed only in well-selected cases: elderly/frail patients with altered lacrimal sacs, epiphora associated with recurrent infections, and failure after dacryocystectomy.
机译:目的:在本研究中,评估了与泪管相关的泪囊切除术的可行性和安全性,用于治疗经复制的泪囊炎和患有受损泪囊的泪囊梗阻的嗜肺腺炎。受试者和方法:32例患者接受泪囊切除术,克劳福国管穴位插入,由单个外科医生进行。术后访问预定于1天和第10天,1,3和6个月。在每次随访中,评估骨膜和泪囊炎的患病率并与基线数据进行比较。此外,我们在随访期间评估了局部和系统性后不良事件的患病率。结果:11名患者(34.38%)报告持续的Epiphora,持续30天后手术后30天。其中,即使在六个月的随访中,9个受试者(28.13%)偶尔偶尔浸润。在手术前的雌细胞腺炎或亚急性肾病的情况下,患者报告了明确的症状分辨率。其他报道的不良事件由于克劳福管突起(4例,12.5%),爬行管挤出案例(3.13%),3例外科伤口裂开(9.36%),持续温和局部出血结论15天:手术后观察到具有可接受的安全性,扩大泪囊切除术治疗的重要性癫痫减少。该程序提供了复发性泪囊炎的令人满意的分辨率。然而,这种方法应该仅在精选良好的情况下进行:老年人/脆弱患者,泪囊的改变,与反复感染相关的胚乳,以及泪囊切除术后失败。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号